Dynamic Contrast Enhancement Computed Tomography Based Technic to Assess Gastro Intestinal Wall Perfusion : Feasibility Study

Mesenteric Ischemia Clinical Trial

— PERFE-CT  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03367065
• Other study ID #: PERFE-CT
• Status: Completed
• Phase: N/A
• Start date: October 2016
• Est. completion date: December 2017

Study information

• Verified date: April 2020
• Source: Poitiers University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This feasibility study has therefore several aims:

1. construct a dedicated CT perfusion protocol for GIT wall perfusion;

2. used a two-compartment pharmacokinetic model which is more adapted that a unique compartment model;

3. from the image acquired, evaluate current parameters of perfusion including the permeability ones

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: December 2017
• Est. primary completion date: November 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• all patients over fifty years old with clinico-biological suspicion for acute GITischemia admitted at our institution

Exclusion Criteria:

• contra-indication to contrast agent injection as so defined by the European Society of UroRadiology in 2014

• inability to provide informed consent

Related Conditions & MeSH terms

• Ischemia
• Mesenteric Ischemia
• Permeability CT Technics

Intervention

Radiation:
• Dynamic contrast enhanced computerised tomography

Locations

Country	Name	City	State
France	Chu Poitiers	Poitiers	Aquitaine

Sponsors (1)

Lead Sponsor	Collaborator
Poitiers University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of computerised tomography with interpretable data		2 hours